Clinical Trial Update: A Study of the Onset and Offset of Antiplatelet Effects Comparing Ticagrelor, Clopidogrel, and Placebo With Aspirin [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated the onset and offset of antiplatelet effects for ticagrelor and clopidogrel compared with placebo when added to aspirin in patients wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: AstraZeneca | Conditions: Coronary Artery Disease | Phase 2 | Status: COMPLETED | Results posted: 2012-01-11